Brighthouse Financial Inc. (0HPH)
London Stock Exchange · UK · prices in USD · close of 28 Oct 2026
Key indicators
| Last close | USD 43.58 |
|---|---|
| 52-week range | 43.52 – 66.80 |
| Return, 1 month / 3 months | −17.7% / −31.2% |
| Return, 1 year / 3 years | −5.3% / −2.7% |
| Trend | Below its 200-day average |
| RSI (14) | 23 |
| Volatility (1 year) | 48.6% |
| Worst drawdown (1 year) | -34.8% |
| Average daily value traded | 0.05M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Brighthouse Financial is an insurance company based in the United States that provides annuities and life insurance to individual customers. Its products include fixed and variable annuities, which help people save for retirement and turn savings into regular income, along with life insurance policies that offer protection for families. The company serves retail customers across the American market through its insurance subsidiaries and a network of distribution partners.
On this site Brighthouse Financial Inc. appears as a stock on the London Stock Exchange (UK), code 0HPH, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Brighthouse Financial Inc. (0HPH) trades on the London Stock Exchange in UK. It last closed at USD 43.58 on 28 October 2026.
Its price-based Market X-Ray is 25 out of 100 (a weak price profile), ranking 3,245 of 3,790 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.3% and over the last three months it fell 31.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 16 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -27.8% | ||
| From 52-week high | -34.8% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -31.2% | ||
| 6-month return | -29.8% | ||
| 12-month return, skipping the last month | 15.1% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.8% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −10.5% |
|---|---|
| 1 month | −17.7% |
| 3 months | −31.2% |
| 6 months | −29.8% |
| 1 year | −5.3% |
| 3 years | −2.7% |
| 5 years | −15.4% |
Signals
| 50-day / 200-day average | 52.38 / 60.39 |
|---|---|
| Golden / death cross (60 days) | Death, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.56 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.